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ABSTRACT. A sustainable MAO-N biocatalyzed process for the synthesis of pyridines from 
aliphatic tetrahydropyridines (THP) has been developed. Pyridine compounds were 
synthesized under mild reaction conditions and with high conversion exploiting MAO-N whole 
cells as aromatizing biocatalysts. The kinetic profile of the whole cell biocatalytic 
transformation was finally investigated via in situ 19F NMR. 
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INTRODUCTION 
The pyridine ring system represents the major class of heterocycles and constitute the key 
structural unit of many pharmaceutical, agrochemical and material compounds.1 Natural 
molecules such as the vitamins niacin and pyridoxine or the ubiquitous redox system 
NADP/NADPH contain a pyridine nucleus as well as many drugs like the antitubercular agent 
isoniazid 1, the analgesic etoricoxib 2 or the anticancer agent sorafenib 3.2 Pyridine derivatives 
also find application in flavor and fragrance industry due to their peculiar olfactory properties 
ranging from the unpleasant fish-like smell of pyridine itself to the fried chicken smell of 2-
pentylpyridine 4 or the peppermint odor of lutidine.3 A plethora of methodologies for the 
synthesis of pyridines has been reported in the literature so far.4 The two most commonly used 
methods to synthesise substituted pyridines are the Hantzsch5 and the Chichibabin syntheses.6 
Both these approaches show some limitations though, often leading to desired pyridines in low 
yields and with the formation of many side products. In addition, the Hantzsch synthesis of 
pyridines is a two steps protocol which requires an oxidation step commonly carried out with 
nitric acid, metal complexes or high temperatures.7 Due to the versatility of pyridine rings and 
their broad use in different research fields, new approaches to access this important class of 
compounds are constantly developed.8  
In an effort to find new, greener and more sustainable routes to access aromatic nitrogen 
heterocycles from aliphatic precursors, we recently discovered that the monoamine oxidase 
MAO-N, variants from Aspergillus niger, can act as aromatizing biocatalysts and can catalyze 
the synthesis of pyrrole derivatives A from 3-pyrrolines B and allylamine substrates9 (Figure 
1). In nature, MAO enzymes are known to metabolize the xenobiotic 1,2,5,6-
tetrahydropyridines (THPs) into pyridine derivatives or pyridinium compounds through an 
aromatization biotransformation. The natural human monoamine oxidase MAO-B catalyzes 
the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into the neurotoxin 1-
methyl-4-phenylpyridinium (MPP+), a toxic metabolite involved in Parkinson’s disease, 
through a double oxidative process via the 1-methyl-4-phenyl-2,3-dihydropyridinium 
(MPDP+) intermediate.10 Inspired by this metabolic biotransformation and as a natural 
evolution of our previous work, we decided to investigate the possibility to exploit MAO-N as 
aromatizing biocatalysts in the synthesis of pyridine derivatives and to develop a robust 
biocatalytic process to access this important class of compounds.  
Herein, the development of an aromatizing biocatalytic protocol for the synthesis of pyridines 
and pyridinium derivatives D from aliphatic THP substrates C using freeze-dried MAO-N 
whole cell biocatalysts under mild conditions is described. In addition, an in-situ 19F-NMR 
kinetic study of the MAO-N whole cell biocatalyzed aromatization reaction is presented. In-
situ NMR allows the real time monitoring and analysis of chemical reactions including 
biocatalytic processes, as previously described.11 However, to the best of our knowledge, no 
examples of in-situ NMR studies on whole cell biocatalyzed transformations have been 
reported yet. 
RESULTS AND DISCUSSION 
The MAO-N mediated aromatization of the THP 5a into the pyridine 6a was first 
investigated. Freeze-dried whole cells containing MAO-N variants D5, D9, and D11 were 
selected on the basis on their known activity and selectivity toward structurally related 
piperidines.12 The THP 5a was suspended in a buffer solution (pH = 7.8) in the presence of 
minimum amount of cosolvent (DMSO or isooctane8) and treated with different MAO-N 
biocatalysts at 37 oC for 18-24h. The conversion (%) of the biotransformation reaction was 
determined by 1H-NMR integration of the crude mixture or by HPLC. Results are reported in 
Table 1. The treatment of 5a with MAO-N variants D5, D9 and D11 in a 1:66 buffer/DMSO 
mixture lead to the desired pyridine 6a with good conversions (entries 1-3) with the best result 
obtained with enzyme D9 (76%). Interestingly, when a DMSO/DMF 1:4 mixture was used as 
cosolvent (1.6% of the whole reaction mixture) an increase in the yield of 6a was observed 
(entry 4).  On the other hand, excellent and greater conversions (>90%, entries 5-7) were 
obtained when isooctane was employed. In the presence of isooctane, the aromatization 
reaction was completed in 18h with all the MAO-N variants and, again, the variant D9 proved 
to be the best biocatalyst. The role of the cosolvent seems to be crucial to some extent for the 
outcome of the reaction as shown in our previous work.9 Isooctane is a water non-miscible 
solvent, which, together with the buffer solution, generates a biphasic system with low mass 
transfer.13 We hypothesised that, even if in small concentration, a water miscible solvent like 
DMSO may have, in the long term, a detrimental effect on the MAO-N biocatalyst leading to 
its progressive inactivation.  On the other hand, in the presence of a non-water miscible solvent 
like isooctane this inactivation could be prevented, thus leading, as final result, to higher 
substrate conversion. Although substrate/product phase transfer mechanisms are not fully clear 
for this biotransformation, it is reasonable to envisage that the aromatization of 5a into 6a could 
occur at or in proximity of the water-solvent interphase. It is also possible that different 
cosolvents affect the permeability of cell membranes of the whole cell biocatalysts, in turn 
aiding the substrate uptake and improving the reaction outcome. Interestingly, as further 
corroboration of the key role of the cosolvent, when the biotransformation was carried out in 
buffer only, the pyridine 6a was obtained with only 80% conversion (entry 8). The 
aromatization of 5a with the nicotine oxidase biocatalyst 6-HDNO E350L/E352D14 was also 
explored, but no conversion was observed and the THP was fully recovered from the reaction 
mixture (entry 9). Finally, as confirmation that the aromatization of 5a is catalyzed by the 
MAO-N, rather than spontaneously promoted by the oxygen in the air or other chemicals and 
side products present in the reaction mixture, a series of blank experiments were carried out. 
When no biocatalyst was added to the reaction mixture (entry 10), no traces of the pyridine 6a 
were detected after 24h, confirming that the MAO-N is responsible for the aromatization of 5a. 
Similarly, the treatment of 5a with E. coli BL21(DE3) cells no harboring MAO-N enzymes 
under optimized conditions did not lead to any pyridine 6a (entry 11). The MAO-N catalyzed 
biotransformations requires oxygen as co-substrate for the oxidation reaction, thereby 
producing H2O2 as a side-product. In order to confirm if the H2O2 formed during the 
biotransformation affects the aromatization of the THP, the oxidation of 5a in the presence of 
the enzyme catalase was investigated. In fact, catalase acts as H2O2 scavenger, converting the 
hydrogen peroxide formed during the MAO-N biocatalyzed aromatization into H2O. When the 
substrate 5a was treated with MAO-N D9 in the presence of catalase, the desired pyridine 6a 
was formed with 72% conversion after 18h (entry 12), thus confirming that the H2O2 has no 
effect (or only minor effect) on the biocatalytic aromatization of THPs into pyridines. As 
further confirmation that H2O2 was not responsible for the aromatization of the THP, the 
substrate 5a was suspended in buffer solution (pH 7.8) at 37 oC and treated with H2O2 30% 
w/w. Only traces (<4%) of the pyridine 6a were detected from the reaction mixture after 24h.  
According to previous studies on the MAO metabolism,10 we assume that the biocatalytic 
aromatization of THP substrates occurs in two steps as shown in Scheme 1. The enzyme MAO-
N catalyzes first the C-N oxidation of 5a leading to the 5,6-dihydropyridinium intermediate 7a. 
This latter can spontaneously aromatize into 6a in the presence of O2 from the air or 
alternatively tautomerize into the intermediate 7b and, eventually, undergoes a second MAO-
N catalyzed C-N oxidation leading to 6a.  
Once the best reaction conditions were identified the scope of the aromatizing 
biotransformation was investigated. A series of THPs 5b-f and 14a-b were synthesised as 
reported in Scheme 2.15 The commercial N-Boc-piperidone was treated with different aryl-
Grignard reagents leading to tertiary alcohol derivatives 8b-e, which were in turn treated with 
TFA leading to 5b-e through dehydratation and concomitant Boc-cleavage (Scheme 2a). The 
synthesis of THP 14a-b was carried out according to the protocol described in Scheme 2b. 
Benzaldehyde or hexanal and allylamine were reacted to form the imines 11a-b, which were 
in turn treated with allylmagnesium bromide in the presence of ZnEt2 and (Boc)2O to afford 
the dienes 12a-b.16 Ring-closing metathesis of 12a-b led to the THPs 13a-b which were finally 
deprotected with HCl/AcOEt to give desired 14a-b as HCl salts. The THPs 5b-f and 14a-b, 
together with the N-methyl-THP 15a-c17 were then treated with the MAO-N whole cell 
biocatalysts. The results are reported in Tables 2 and 3. The THP 5b was fully converted (99%, 
entry 1) into pyridine 6b by MAO-N D9 when the reaction was carried out in buffer/isooctane 
mixture. Comparable conversions were observed with MAO-N D5 and D11, whilst slightly 
lower conversions were obtained when DMSO was used as cosolvent. The pyridines 6c-d were 
also obtained with excellent conversions (entries 2-3), in particular when additional loading of 
the MAO-N biocatalysts was used in the course of the reaction. The chloro-derivative 6e was 
obtained in slightly lower amount (57%, entry 4),18 while the bromo-derivative 6f was formed 
with only 34% conversion (entry 5) probably due to the steric hindrance of the halogen 
substituent on the phenyl ring. The N-methyl derivatives 15a-b were fully converted (99-87%) 
into the desired pyridinium ions 16a-b by the MAO-N D9 biocatalyst. On the other hand, 
arecoline 15c, a THP bearing an electron withdrawing substituent, was not converted into the 
desired pyridinium 16c even when higher biocatalyst loading and longer reaction times were 
employed. The THPs 14a-b bearing a stereocentre at C6 were only partially converted by 
MAO-N D9 and D11 into the corresponding pyridines 17 and the flavoring agent 4 (Table 3). 
These results were not unexpected, since it is well documented that MAO-N biocatalysts can 
stereoselectively oxidize one enantiomer over the other in chiral amines. In fact, MAO-N 
enzyme selectively aromatized the enantiomers (S)-14a-b into pyridines 17 and 4 (entries 1-
2), whilst the opposite enantiomers (R)-14a-b were recovered from the reaction mixture as 
major products with approximately 20% ee.19 It is also plausible that factors (i.e. steric factors) 
may contribute to the low conversion observed for 14a-b. Attempts to increase the conversion 
of 14a-b by increasing the catalyst loading or the reaction time were unsuccessful. 
The MAO-N whole cell biocatalyzed aromatization of THP 5d was finally investigated by 
in situ 19F NMR spectroscopy. The experiment was carried out under standard conditions 
(buffer pH 7.8, isooctane cosolvent, 37 oC) using the whole cell biocatalyst MAO-N D9. 
Attempts to monitor the biocatalytic aromatization of THP substrates via in situ 1H NMR 
proved to be tricky due to the interference caused by the cells in the reaction mixtures, as well 
as the cosolvent.20 The THP 5d, bearing a fluorine atom, was thus chosen as candidate for the 
in situ NMR experiments, as it would allow monitoring of the 19F nucleus with less 
interferences arising from the whole cell biocatalyst. The substrate 5d was suspended in buffer 
solution containing 1.6% isooctane and treated with MAO D9 at 37 oC. The reaction was 
monitored for 24h during which time 19F NMR experiments were recorded in sequence every 
15 minutes (number of scans: 128) using the proton-decoupled 19F sequence. A selected 
number of 19F NMR spectra is reported in Figure 2a. After approximately 90 min from the 
addition of the biocatalysts to the reaction mixture, a signal at -113.61 pm belonging to the 
pyridine 6d appeared in the NMR spectrum and it became clearer after 120 min. The intensity 
of the signal at -115.56 ppm belonging to the substrate 5d start to decrease already after 30 min 
and the signal disappear completely after 10h with concomitant increase of the 6d fluorine 
peak. According to the in-situ NMR experiment the reaction was completed within 12h. As the 
integration of the peaks is proportional to the concentration of the species involved, the kinetic 
profiles of each species were reported by plotting the integration of each peak against the time 
(Figure 2b). The less sharp and defined signals of 6d, compared to 5d, are most likely due to 
residues of the biocatalyst (cells and their organelles present in the reaction mixture) or affinity 
of the substrate to the cell membranes, which, limiting the mobility of the compounds, may be 
responsible for the broadening of the fluorine peak. To confirm the full conversion of the 
biotransformation, the reaction was stopped after 24h, extracted and the crude mixture was 
purified affording THP 6d in 87% isolated yield.21 Interestingly, the 19F signal of 6d starts to 
appear after a consistent time (more than 90 min) while the signal of 5d start to decrease after 
few minutes. It is likely that during the first phase of the biotransformation, the THP 5d is 
converted into the partially oxidized intermediates 7 (Scheme 1) before being fully aromatized 
into 6d. A weak signal at around -108.75 ppm was detected by 19F-NMR spectra after 30 min. 
This peak disappears completely after 4h and it might belong to intermediates 7.22 It is plausible 
that the low concentration and short half-life of intermediates 7 over the reaction time, as well 
as the interference caused by the whole cell biocatalyst, made their detection not clearly 
evident. 
CONCLUSIONS 
In conclusion, an efficient biocatalytic protocol for the synthesis of pyridines from aliphatic 
tetrahydropyridine precursors exploiting MAO-N whole cell biocatalysts has been described. 
The methodology represents a mild, alternative and more sustainable approach to access 6-
membered nitrogen heterocycles through the aromatization of aliphatic substrates. In 
particular, the biocatalyst MAO-N D9 was found able to catalyze the biotransformation of a 
variety of aryl-THPs into aryl pyridines 6 and pyridinium ions 15 with excellent conversions 
by mimicking the natural metabolic activity of human MAO enzymes. Also the challenging 
chiral THP substrates 14a-b were partially converted into the pyridine 17 and the flavouring 
agent 4. Finally, the first example of in situ 19F NMR study of a whole cell biocatalyzed reaction 
was reported. 
 
 FIGURES.  
 
Figure 1. Pyridine nucleus containing drugs and flavoring agents 
 
 Figure 2. a) Stacked in situ 19F NMR spectra of the aromatization of 5d using MAO-N D9 
whole cells. b) The kinetic profile of the reaction shows the disappearance of 5d and the 
formation of the pyridine product 6d. 
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SCHEMES. 
 
Scheme 1. Plausible mechanism of MAO-N biocatalytic aromatization. 
 
 
Scheme 2. a) Synthesis of aryl THPs 5b-e. b) Synthesis of chiral THPs 14a-b  
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TABLES.  
Table 1. Biocatalytic aromatization of THP 5a 
❖
◼
◆
◼

◆

❖
 
Entry MAO-Na Cosolvent (1.4%) Time (h) Conv. (%)b 
1 D5 DMSO 24 70 
2 D9 DMSO 24 76 
3 D11 DMSO 24 67 
4 D9 DMSO/DMF 1:4 24 95 
5 D5 isooctane 18 92 
6 D9 isooctane 18 98f 
7 D11 isooctane 18 95 
8 D9 - 15 80 
9 6-HDNO DMSO 24 0 
10 - c DMSO 24 0 
11 - d DMSO 24 0 
12 D9e isooctane 24 72 
aFreeze-dried whole cells (140mg / 0.1mmol of 5a) were used. Conditions are reported in the Supporting 
Information.   bConversion was determined by 1H-NMR integration of the crude mixture or by HPLC 
analysis using a Chiralpak IG column. cNo biocatalyst was added to the reaction mixture. dE. coli 
BL21(DE3) cells no harboring MAO-N enzymes were used. eCatalase was added to the reaction mixture. 
fLarge scale reaction afforded 6a with 99% conv. and 75% isolated yield 
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Table 2. Biocatalytic aromatization of THPs 5b-f and 15a-c  
 
Entry THP R 
MAO-
Na 
Cosolvent 
(1.4%) 
Time 
Pyridine/ 
pyridinium 
Conv. (%)b 
1 5b 4-(4-Me-Ph) 
D5 DMSO 20h 
6b 
65 
D9 DMSO 20h 85 
D11 DMSO 20h 72 
D5 isooctane 20h 93 
D9 isooctane 20h 99 
D11 isooctane 20h 95 
2 
  D9 DMSO 24h  63 
  D9 DMSO 48h  73 
5c 4-(4-MeO-Ph) D9c DMSO 24h 6c 98 
  D9 isooctane 24h  70 
  D11 DMSO 24h  58 
3 5d 4-(4-F-Ph) 
D9 DMSO 24h 
6d 
50 
D9 DMSO 48h 55 
D9c DMSO 24h 98 
D9 isooctane 24h 54 
D11 isooctane 24h 28 
4 5e 4-(4-Cl-Ph) D9 DMSO 24 6e 55 
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D9c DMSO 24h 57 
5 5f 4-(4-Br-Ph) 
D9 
D9 
D9c 
D11 
isooctane 24 h 
6f 
20 
34 
30 
16 
DMSO 24 h 
isooctane 24 h 
isooctane 24 h 
6 15a 4-Ph D9 isooctane 24h 16a 99 
7 15b 3-Ph D9 isooctane 24h 16b 87 
8 15c 3-COOMe D9 isooctane 24h 16c 0 
aFreeze-dried whole cells were used. bConversion was determined by 1H-NMR integration of the crude 
mixture or by HPLC analysis using a C18 reverse phase column (for compounds 16a-c). cAdditional amount 
of MAO-N D9 (140 mg / 0.1 mmol substrate) was added after 9 h. 
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Table 3. Biocatalytic aromatization of THPs 14a-b  
 
Entry THP MAO-N 
Pyridine/THP 
ratio. (%)a 
(R)-14a-b 
ee (%)c 
1 14a 
D9 25:75 21 
D9b 26:74 - 
D11 24:76 20 
2 14b 
D9 18:82 - 
D9b 26:74 - 
D11 24:76 - 
aThe ratio between the pyridine product (17 or 4) and the unreacted THP (14a-b) was determined by HPLC 
using a Chiralpak IG column. bAdditional amount of MAO-N D9 (140 mg / 0.1 mmol substrate) was added 
after 9h. cThe ee of unreacted THP was determined by GC using a Beta-DEX 325 Capillary Column.  
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